Molecular computation by the CaMKII holoenzyme
CaMKII 全酶的分子计算
基本信息
- 批准号:10535139
- 负责人:
- 金额:$ 3.62万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-08-01 至 2025-07-31
- 项目状态:未结题
- 来源:
- 关键词:AddressAffinityAvidityBindingBiochemicalBiochemistryBiophysicsCalmodulinCellsCognitionCognitiveComplexDataDevelopmentExcitatory SynapseFluorescenceFrequenciesGeometryHippocampus (Brain)HoloenzymesImpairmentIn VitroIndividualLearningLong-Term PotentiationMediatingMediator of activation proteinMemoryMental DepressionModelingMolecularMolecular ComputationsMutateN-Methyl-D-Aspartate ReceptorsNegative StainingNeurodegenerative DisordersNeuronsPhosphotransferasesPositioning AttributeProcessProteinsReactionRegulationRoleSignal TransductionSpectrum AnalysisStimulusStructureSynapsesSynaptic plasticityVariantcalmodulin-dependent protein kinase IIdimerexperimental studyinsightmonomermutantnervous system disorderneuropsychiatric disorderresponsespatiotemporalstoichiometrythree dimensional structuretooltraining opportunity
项目摘要
PROJECT SUMMARY
Learning, cognition, and memory require dynamic remodeling of hippocampal synapses, which in turn requires
Ca2+/calmodulin-dependent kinase II (CaMKII). CaMKII mediates two opposing modes of synaptic plasticity, long
term potentiation (LTP) and depression (LTD), that are induced by distinct Ca2+ stimuli. Both low and high Ca2+
induce CaMKII autophosphorylation (p) at T286, that is required for both LTP and LTD. Additionally, LTP requires
CaMKII binding to the NMDA receptor subunit, GluN2B, during high [Ca2+] while LTD requires CaMKII
autophosphorylation at T305/306 during low [Ca2+]. Further, these three mechanisms can undergo complex
cross-regulation which requires the CaMKII 12-meric holoenzyme. Interestingly, pT286 positively regulates both
GluN2B binding and pT305/306 while GluN2B binding and pT305/306 are mutually exclusive. It is unknown how
these reactions and interactions are spatiotemporally encoded within holoenzymes and thus how LTP versus
LTD signal computation is accomplished by CaMKII. For example, it has been shown that pT286 must occur
between two neighboring kinase domains in the holoenzyme. It is still unclear what determines a functional
kinase domain neighbor. Moreover, in vitro binding studies have shown that CaMKII holoenzymes are required
for binding to GluN2B, suggesting that this interaction may require multiple subunits. Still, it is unknown what is
the required stoichiometry and subunit geometry required for CaMKII-GluN2B binding. Initial results suggest that
the holoenzyme rules for pT286 and GluN2B binding are fundamentally different. Therefore, this proposal will
investigate my hypothesis that LTP versus LTD mechanisms are regulated by structurally distinct features within
CaMKII holoenzymes. The approach will utilize several CaMKII “structural mutants” that have disrupted
holoenzyme structure (hexamers, dimers, and monomers). These mutants will be used as tools to define the
spatiotemporal dynamics of autophosphorylation within holoenzymes and the subunit stoichiometry and
geometry required for GluN2B binding. The results of this proposal will provide insight into how molecular signal
computation underlying the LTP versus LTD decision is encoded within CaMKII holoenzymes.
项目摘要
学习,认知和记忆需要动态重塑海马突触,这又需要
Ca2+////// calmodulin-dipentent激酶II(CAMKII)。
术语增强(LTP)和抑郁症(LTD),由不同的Ca2+刺激引起。
在T286处诱导Camkii自磷酸化(P),这是LTP和LTD所必需的
CAMKII在高[Ca2+]期间与NMDA受体亚基Glun2b结合,而LTD需要CAMKII
在低[Ca2+]的T305/306处的自磷酸化。
跨阀需要CAMKII 12-MERIC HOLOENZYME。
glun2b结合和pt305/306,而glun2b结合和pt305/306是互斥的。
这些反应和相互作用是在全酶内部编码的,因此LTP与
LTD信号计算是由CAMKII完成的。
在全酶中的两个相邻的激酶结构域之间,仍然不清楚什么是确定功能
此外,激酶结构域。
要与glun2b结合,表明这种相互作用可能需要多个亚基。
CAMKII-GLUN2B结合所需的化学计量和亚基几何形状。
PT286和Glun2b结合的全酶规则是基本的。
调查我的假设,即LTP与LTD机制是由结构内的不同特征定制的
camkii全酶将使用干扰
全酶结构(六聚体,二聚体和单体)。
全酶内自噬的时空动力学和亚基在
Glun2b结合所需的几何形状。
LTP与LTD决策的基础计算是编码CAMKII Holoenzymes中的。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Carolyn Nicole Brown其他文献
Carolyn Nicole Brown的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Carolyn Nicole Brown', 18)}}的其他基金
Molecular computation by the CaMKII holoenzyme
CaMKII 全酶的分子计算
- 批准号:
10754843 - 财政年份:2022
- 资助金额:
$ 3.62万 - 项目类别:
相似国自然基金
抗原非特异性B细胞进入生发中心并实现亲和力成熟的潜力与调控机制
- 批准号:32370941
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
面向免疫疗法标志物识别的基于多特征融合的肽与MHC亲和力预测研究
- 批准号:62302277
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于计算生物学技术小分子农兽药残留物驼源单域抗体虚拟筛选与亲和力成熟 -以内蒙古阿拉善双峰驼为例
- 批准号:32360190
- 批准年份:2023
- 资助金额:34 万元
- 项目类别:地区科学基金项目
基于胞内蛋白亲和力标记策略进行新型抗类风湿性关节炎的选择性OGG1小分子抑制剂的发现
- 批准号:82304698
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
面向多场景应用的药物-靶标结合亲和力预测研究
- 批准号:62371403
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
相似海外基金
A simulation platform to predict dose and therapeutic window of immunocytokines
预测免疫细胞因子剂量和治疗窗的模拟平台
- 批准号:
10698708 - 财政年份:2023
- 资助金额:
$ 3.62万 - 项目类别:
TNFRSF13B polymorphisms and immunity to transplantation
TNFRSF13B 多态性与移植免疫
- 批准号:
10734879 - 财政年份:2023
- 资助金额:
$ 3.62万 - 项目类别:
Selective Activators of Nrf2 for Neurodegenerative Disease
Nrf2 选择性激活剂治疗神经退行性疾病
- 批准号:
10758091 - 财政年份:2023
- 资助金额:
$ 3.62万 - 项目类别:
CD98hc Brain Shuttles for Delivering Off-the-shelf Neuroprotective Antibodies in Alzheimer's Disease
CD98hc 脑穿梭机为阿尔茨海默病提供现成的神经保护抗体
- 批准号:
10566062 - 财政年份:2023
- 资助金额:
$ 3.62万 - 项目类别:
Modulating Fibrinolysis Dynamics by Leveraging Multivalent Avidity to Control Enzyme Activity
通过利用多价亲和力控制酶活性来调节纤维蛋白溶解动力学
- 批准号:
10635496 - 财政年份:2023
- 资助金额:
$ 3.62万 - 项目类别: